| Application no. and date | 09782777.8 (espacenet) (Federated) (European Patent Register), 20090908 | | Patent/reg. no. and date | DK/EP 2331537, 20151028 | | Publication date | 20110615 | | Priority no. and date | EP 08164104, 20080910, US 96674 P, 20080912 | | EP pub. no. and date |
EP 2331537 20110615 | | Effective date | | | Applicant/owner | Novartis AG, Lichtstrasse 35
4056 Basel, CH | | Applicant ref. no. | SH/AP/152298 | | Inventor | FAIRHURST, Robin Alec, Novartis Horsham Research Centre
Wimblehurst Road
Horsham Sussex RH12 5AB, GB,
FURET, Pascal, Novartis Pharma AG
Werk Klybeck
Postfach
CH-4002 Basel, CH,
GUAGNANO, Vito, Novartis Pharma AG
Werk Klybeck Postfach
CH-4002 Basel, CH,
CARAVATTI, Giorgio, Novartis Pharma AG
Werk Klybeck
Postfach
CH-4002 Basel, CH,
IMBACH, Patricia, Novartis Pharma AG
Werk Klybeck
Postfach
CH-4002 Basel, CH | | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | | Opponent | | | IPC Class | A61K 31/4439 (2006.01) , A61P 35/00 (2006.01) , C07D 417/14 (2006.01) | | Title | 1-((5-Heteroarylthiazol-2-yl)aminocarbonyl)pyrrolidin-2-carboxamid-derivater som til behandling af proliferationssygdomme anvendelige phosphatidylinositol-3-kinase-(PI3K-)inhibitorer | | Int. application no. | EP2009061644 | | Int. publication no. | WO2010029082 | | Related patent (certificate) | CA 2020 00054 | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
